Your browser doesn't support javascript.
loading
Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles.
Goodman, Joanne; Cowen, Simon; Devanarayan, Viswanath; Egging, David; Emrich, Thomas; Golob, Michaela; Kramer, Daniel; McNally, Jim; Munday, James; Nelson, Robert; Pedras-Vasconcelos, João A; Piironen, Timo; Sickert, Denise; Skibeli, Venke; Fjording, Marianne Scheel; Timmerman, Philip.
Afiliação
  • Goodman J; MedImmune, Aaron Klug Building, Granta Park, Cambridge, Cambridgeshire, CB21 6GH, UK, +44 (0) 203 749 6244, +44 (0) 1223 471472.
  • Cowen S; LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK.
  • Devanarayan V; Charles River Laboratories, 905 Sheehy Dr, Horsham, PA 19044; formerly located at Abbvie during the production of this manuscript.
  • Egging D; Synthon, Microweg 22, P.O. Box 7071, 6503 GN Nijmegen, The Netherlands.
  • Emrich T; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany.
  • Golob M; Nuvisan GmbH, Am Feld 32, 85567 Grafing, Germany.
  • Kramer D; Sanofi Aventis Deutschland GmbH, Industriepark Höchst, D-Frankfurt am Main, Germany.
  • McNally J; Shire, 300 Shire Way, Lexington MA 02421; formerly located at Merck Serono during production of this manuscript.
  • Munday J; Covance Laboratories Ltd, Otley Road, Harrogate, HG31PY, United Kingdom.
  • Nelson R; Novimmune SA, 14 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland.
  • Pedras-Vasconcelos JA; US Food and Drug Administration/Center for Drugs Evaluation and Research/Office of Biotechnology Products/Division of Biotech Review and Research 3, MD, USA.
  • Piironen T; Syrinx Bioanalytics, Pansiontie 47, Biohouse D5, 20210 Turku, Finland.
  • Sickert D; Novartis, Kohlenstrasse, WSJ-386.13.05.14, CH-4056 Basel, Switzerland.
  • Skibeli V; Norwegian Medicines Agency, Stroemsveien 96, Postboks 6167 Etterstad, 0602 Oslo, Norway.
  • Fjording MS; Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Måløv, Denmark.
  • Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, 1000 Brussels, Belgium.
Bioanalysis ; 10(4): 197-204, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29345496
ABSTRACT
European Bioanalysis Forum Workshop, Lisbon, Portugal, September 2016 At the recent European Bioanalysis Forum Focus Workshop, 'current analysis of immunogenicity best practices and regulatory hurdles', several important challenges facing the bioanalytical community in relation to immunogenicity assays were discussed through a mixture of presentations and panel sessions. The main areas of focus were the evolving regulatory landscape, challenges of assay interferences from either drug or target, cut-point setting and whether alternative assays can be used to replace neutralizing antibody assays. This workshop report captures discussions and potential solutions and/or recommendations made by the speakers and delegates.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Imunoensaio / Tolerância a Medicamentos / Anticorpos Neutralizantes Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Imunoensaio / Tolerância a Medicamentos / Anticorpos Neutralizantes Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article